Ambulero
Biotechnology Research
1951 Nw 7th Ave
3 employees
- Employees
- 3
- Contacts
- 1
- Emails
- 1
- Phones
- 1
Ambulero Overview
- Headquarters
- 1951 Nw 7th Ave
- Website
- ambulero.com
- Industry
- Biotechnology Research
- Employees
- 3
- Founded
- 2019
- Funding
- 5.5M
- Company Email
- Available in AeroLeads
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
About Ambulero
Ambulero is a cell and gene therapy spin-out of the University of Miami focused on advancing new therapies to fight vascular disease. We are a platform company that can deliver the adhesion molecule E-selectin using different cell and synthetic vector technologies. We work on rare vascular diseases as well as more common indications effecting large patient populations.
Ambulero Contact Details
- People in AeroLeads
- 2
- With contact data
- 1
- Email contacts
- 1
- 50.0% coverage
- Phone contacts
- 1
- 50.0% coverage
Ambulero Org Chart
Sample employees and titles| Name | Title | Location | Contact |
|---|---|---|---|
| Randy Berholtz | Co-founder, Vice President, Business | San Diego, California, United States |
Email
Phone
|
| Khemraj Hirani | Transformational Clinical, Quality |
View
|
Compare Similar Companies to Ambulero
JTM Construction
Construction
Ventac Partners
Investment Management
Orbit Genomics
Biotechnology Research
Chosan
Real Estate
Pacific Coast Electrical Contractors, Inc.
Construction
Eysz
Medical Device
RORA Biologics
Biotechnology Research
Ambulera Group
Manufacturing
CHIYING Trading Co., ltd.
Software Development
FastBack Bio LLC
Related company record